C0057605_Pharmacokynetic_C0051923

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C0007681>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	increase
?:interaction	Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Anisotropine methylbromide.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0051923>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB00517>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C0057605>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB00405>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction> <https://research.tib.eu/covid-19/vocab/PharmacokyneticDrugDrugInteraction>

Metadata

Anon_0

expand all